Tigress Financial Raises Intel Price Target to $145 Following Terafab Deal

Tigress Financial Partners has raised its price target for Intel Corp. (NASDAQ: INTC) to $145 from $118, maintaining a Buy rating. The firm cited the company’s role in the Terafab project as a primary reason for this revision. This change reflects increased confidence in Intel’s turnaround strategy and its growing foundry business.

"The company’s AI-driven turnaround is gaining strategic credibility," said Ivan Feinseth, analyst at Tigress Financial, in a recent note. He added that fundamental catalysts are improving Intel’s competitive position in data-center computing, AI PCs, and advanced semiconductor manufacturing.

The Terafab Partnership

Intel serves as the primary foundry provider for Terafab, a chip manufacturing venture between Tesla Inc. and Space Exploration Technologies Corp. (SpaceX). The project is valued at $25 billion and represents an industrial commitment to domestic semiconductor production.

Analysts view the partnership as an indicator of Intel’s manufacturing viability. According to Feinseth, the collaboration serves as a bellwether for the company's future:

"Terafab could provide external validation of INTC’s engineering capabilities, create a significant advanced-foundry customer opportunity, and increase utilization across its fabrication and packaging network," Feinseth noted.

Strategic Implications for Intel

Intel’s transition toward an IDM 2.0 model, which focuses on designing its own chips while manufacturing chips for third-party clients, has been a focal point for market observers. By securing a partnership with a high-capital entity like the Tesla-SpaceX venture, Intel aims to prove it can handle the demands of next-generation silicon production at scale.

Increased utilization of its fabrication and packaging network is essential for Intel’s profitability. The company seeks to offset the high fixed costs associated with building and maintaining semiconductor manufacturing facilities. The partnership with Terafab is expected to provide a consistent pipeline of demand as the facility moves toward full operational capacity.